{"nct_id":"NCT06736262","title":"A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-07","start_date":"2024-11-26","start_date_type":"ACTUAL","primary_completion_date":"2026-12-01","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JSPR"]}